MAP2K4 and central nervous system cancer: Overall, the present study showed that ZDHHC17 was up-regulated in glioma as compared to normal brain tissue, and that it recruited MAP2K4 and JNK/p38 to build a signaling module for JNK/p38 activation in GBM.